Table III. Relation of percentage adverse events (mild and severe) to hydrops, severity of anemia (Z-Hb), gestational age at IUT and location of transfusion.
Uneventful IUT | Adverse events (mild and severe) | p-value | Nr severe adverse events | |
Hydrops non | 109 (92%) | 10 (8%) | < 0.001 | 1 |
Hydrops mild | 10 (83%) | 2 (17%) | 0 | |
Hydrops severe | 2 (50%) | 2 (50%) | 1 | |
Mean Z-Hb | -5.3 SD | -5.9 SD | 0.11 | |
IUT < 20 weeks | 3 (100%) | 0 (0%) | 0.56 | 0 |
IUT 20-34 weeks | 99 (88%) | 13 (12%) | 2 | |
IUT > 34 weeks | 19 (95%) | 1 (5%) | 0 | |
Cord root transplacental | 56 (93%) | 4 (7%) | < 0.001 | 0 |
Cord root transamniotic | 3 (75%) | 1 (25%) | 0 | |
Free loop | 20 (77%) | 6 (23%) | 2 | |
Intrahepatic | 36 (92%) | 3 (8%) | 0 |